08 Mar 2021 Avacta’s Rapid Antigen Test is Confirmed to Detect SARS-CoV-2 New Variants Diagnostics | Investors
24 Feb 2021 Business Update: Significant momentum in both Diagnostics and Therapeutics Divisions Investors
18 Feb 2021 Phase I Clinical Trial Authorisation for AVA6000 Approved by MHRA Investors | Therapeutics
16 Feb 2021 Results of Initial Evaluation of SARS-CoV-2 Lateral Flow Antigen Test with Clinical Samples Diagnostics | Investors